Research Interest: The role of mitochondrial and synaptic alterations in neurological disorders. We use proteomics, biochemical, pharmacological and behavioral tools to identify drug targets and biomarkers for diverse neurological disorders.
Research Interest: Our laboratory is designing novel molecules targeting RNA, RNA-binding proteins, and disease-associated protein complexes to address unmet medical needs. We specialize in induced-proximity strategies, including molecular glues and bifunctional chimeras, to selectively modulate or eliminate pathogenic targets in cancer and other complex diseases. In the context of the Multidisciplinary Center for Cannabinoid Research, we focus on targeting the CB1 receptor and developing molecules that induce its selective degradation as a novel therapeutic approach for cancer and metabolic diseases associated with CB1R dysregulation.
Research Interests: The main goal of my lab is to study how pain- and itch-related information is encoded and transmitted by the peripheral and central neurons in normal and pathological conditions. Based on the understanding of the molecular and biophysical mechanisms of detection and transmission of noxious stimuli we also aim to develop new approaches for selective targeting pain- and itch-generating neurons as well as tumor cells.
Research Interest: Cannabis and anesthesia/ cannabis and acute and chronic pain/ long acting local anesthetics/ bench to market cannabis clinical research
Keywords: cannabis, pain, anesthesia, local anesthesia.
Research Interest: Skeletal mobility is largely dependent on the function of our joints. The thin hyaline cartilage layer covering our bones form cushions that allow us to comfortably perform all types of physical activities. Aside from these functions, healthy cartilage is required for normal skeletal development and throughout our lives protects bones from erosion, by functioning as a shock absorber during moderate or intense activity. Our lab is exploring the myriad roles of the endocannabinoid system and sirtuins within the the context of cartilage biology, during aging and skeletal development.
Research Interest: We are interested in various aspects of the cannabinoid system in patients with epilepsy and in cannabinoid distribution within the human body.
Affiliation: Computational Medicinal Chemistry, Institute for Drug Research, School of Pharmacy and Fraunhofer Project Center for Drug Design and Delivery
The Goldblum Lab focuses on the computational design of multi-targeted drugs to treat multifactorial diseases by combining and developing our in-house algorithms with other programs.
Key Words: Depression, Diabetes, Hypercholesterolemia, Malaria, Viral and Bacterial Infections, Cancer Microenvironment, Osteoarthritis, Duchenne Muscular Dystrophy, Aging, Sugar Substitutes, High Energy Materials, Classification, Computational Medicinal Chemistry, Iterative Stochastic Elimination Algorithm
Research Interest: Our lab is focused on investigating the cardiovascular safety of medical cannabis, particularly given its increasing use among oncology patients and the gaps in current cardiovascular safety data.
Key Words: cardiovascular safety, medical cannabis, CBD, THC, oncology, anthracycline, immune check point inhibitors, cancer, cardiotoxicity.
Research Interest: The role of endocannabinoids in allergic inflammation and the role of endocannabinoids in synergism with pro-resolving lipid mediators in resolution of allergic inflammation.
Research Interest: Safety and efficacy of medical cannabinoids
Specific Research Topics on Cannabinoids:
To evaluate the safety and efficacy profile of medical cannabinoids in children in children with refractory epilepsy, chemotherapy-induced nausea and vomit, and autism.
To characterize the population at risk for negative mental emotions in adults exposed to cannabis.
To evaluate the risk of mental illness in medical cannabis patients.
Key Words: medical cannabis, mental health, psychosis, schizophrenia, children
Capabilities for Scientific Collaborations and Services
Research Interest: I have a broad background in oncology, geriatrics, bio-statistics and medical innovation. Since I established a cannabis clinic in 2013, more than 3,100 licenses have been granted for the medical use of cannabis combined with conducting a clinical trial in early order to assess the impact of cannabinoids on solid tumors (ClinicalTrials.gov, NCT02255292), in collaboration with Prof. Rafael Meshulam.
The antiviral activity of CBD. Since we find viruses in Alzheimer’s disease brains, and since CBD has known antiviral activity, we would like to test the therapeutic potential of cannabinoids against brain-infecting viruses.
Research Interest: The main research trust of the lab is microbes attached to surfaces (biofilms). We investigate “life” in the biofilm as each biofilm differs from another. We examine microbes immobilized in biofilm on: transcriptomic, proteomic, metabolomic, levels using techniques as computational analysis alongside with biochemical methods. Next, we develop new means to affect the biofilm (drugs and drug delivery technologies). Among them are cannabinoids and endocannabinoids.
Research Interest: Our lab is focused on uncovering the involvement of the endocannabinoid system in the pathogenesis of obesity and its metabolic complications, with therapeutic prospects for the development of an effective drug therapy.
Research Interest: My research focuses on elucidating the neurobiological basis of major psychiatric disorders: depression, anxiety, and PTSD. We apply cutting-edge molecular, cellular, and circuit-level technologies to map disease-relevant changes with high precision and pinpoint convergent mechanisms shared across these highly comorbid conditions. Our ultimate goal is to translate these discoveries into novel, mechanism-based drug targets and therapeutic strategies that can more effectively prevent or treat stress- and trauma-related psychiatric illness.
Research interest: Understanding the molecular mechanism that underlies the neuroprotective effects of the cannabinoid system in different pathophysiological conditions.
The Hebrew University websites utilize cookies to enhance user experience and analyze site usage. By continuing to browse these sites, you consent to our use of cookies.
